What we do
DELIVERING
THE PROMISE
OF TARGETED
RNA MEDICINES
NanoGenics is a leading RNA therapeutics company.
We are committed to developing cutting-edge gene silencing and gene enhancing medicines using our proprietary gene delivery technology, LipTide.
Read more about what we do...
OUR PRODUCTS
Our lead product, ECP-105, is our novel glaucoma product that enhances the effectiveness of BLEB surgery.
We expect to get ECP-105 into the clinic in 2025.
Our Delivery
LipTide is a revolutionary peptide nanoscale delivery vehicle invented to mimic a natural virus for targeted delivery of RNA into cells.
With appealing clinical properties, the capability to deliver genetic material to almost any cell type, low toxicity, and repeat dosing, the LipTide technology represents new promise across several therapeutic areas of unmet need.
OUR TEAM
Contact Us
Get in touch to learn more about how we are taking our products from concept to clinic.
